Template:Template sandbox: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Blanked the page)
Tag: Blanking
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Cryptococcus neoformans==


Keywords (immunodeficiency): HIV, antiretroviral therapy, oropharyngeal thrush, hepatosplenomegaly, central umbilication, central necrosis, hemorrhagic crust.
*Cryptococcus neoformans is an encapsulated yeast
*Occurs in patients with advanced HIV (CD4<100/mm3)
*The most common manifestation is meningoencephalitis
*Pulmonary and/or disseminated disease may occur
*Cutaneous cryptococcosis considered as a marker of disseminated disease
*Rapid onset (2 weeks) of multiple widespread papular lesions with central umbilication
*Diagnostic clue is the presence of a small area of central hemorrhage or necrosis
*Resembles molluscum contagiosum
*Most common areas affected are head and neck
*Disseminated infections can affect liver, lymph nodes, peritoneum, adrenal gland, and eyes
*Diagnosis
**Biopsy of the lesion
**Histopathological examination after staining (periodic acid-Schiff, Gomori methenamine silver nitrate)
**Hyperplasia of the overlying dermis with underlying granulomas surrounding encapsulated yeasts
**Fungal blood culture is often positive in severe disseminated cryptococcal disease but a biopsy is more sensitive and specific than blood culture (because untreated HIV patients have multiple ongoing opportunistic infections)
**Serum antigen testing can be useful for the diagnosis
**The most common wrong answer is skin scrapings with a microscopic evaluation which is used for the diagnosis of fungal infections as tinea or candidiasis.
*Treatment:
**>/= 2 weeks of IV amphotericin B plus oral flucytosine
**Followed by a year of oral fluconazole (higher dose for 8 weeks, then maintenance)
DD:
*Kaposi Sarcoma:
**Primarily presents in homosexual men(men with HIV who are sexually active with other men)
**Red or purple papules with no necrosis
*Disseminated Mycobacterium avium complex:
**Common opportunistic infection
**Affects patients with advanced AIDS
**Presents as fever, night sweats, abdominal pain, diarrhea, weight loss
**Cutaneous lesions are uncommon and are usually nodular and ulcerating
*Pyoderma gangrenosum:
**Rare neutrophilic dermatitis
**Associated with inflammatory bowel disease and inflammatory arthritides
**Presents as a tender papule that degrades into a bluish, violaceous ulcer
*Basal cell carcinoma
**Single, pink, flesh-colored papules
**Arise slowly
==Tuberculosis==
*Active pulmonary tuberculosis
**Due to reactivation of the latent disease
**Epidemiologic risk factors
***Substance abuse
***Homelessness
***Birth in a TB-endemic region
**Clinical manifestations
***Fever, cough >2 weeks, weight loss
Diagnosis:
*Chest x-ray
**signs of active disease (upper lobe cavitation 970-80%), hilar lymphadenopathy, or pleural effusion.
*Definitive diagnosis of suspicious x-ray finding by isolation of Mycobacterium tuberculosis in body fluid or tissues (lung, pleura)
*Sputum sampling (acid-fast bacilli smear and culture)
**Least invasive and costly route for microbial confirmation
**Three single sputum samples (spontaneous or induced) are submitted in 8- to 24-hour intervals with at least 1 early-morning sample
**Sputum should be sent for acid-fast bacillus smear, mycobacterial culture, and nucleic acid amplification testing.
*Tuberculin skin test and interferon-gamma release assay
**both can only support the diagnosis and if positive suggest exposure
**Can't distinguish between active and latent disease
*Bronchoscopy with bronchoalveolar lavage
**More invasive and expensive than sputum sampling
**Reserved for patients who are
***Unable to produce adequate expectorated or induced sputum
***Have negative sputum studies with a high suspicion for active TB
***Have possible alternate diagnosis that requires bronchoscopy for evaluation
*Transthoracic needle aspiration
**Invasive and associated with greater risk of complications
**Typically reserved for patients who remain undiagnosed after less invasive tests (sputum, bronchoscopy with bronchoalveolar lavage)
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Diagnosis}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Sensitivity}}
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF|Specificity}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|BCG vaccine}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Cost effective}}
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF|Latent vs active TB}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| TB vs non-TB mycobacteria}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Result}}
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Tuberculin skin test|Tuberculin skin test]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Interferon gamma release essay|Interferon gamma release essay]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Interferon gamma release essay|Interferon gamma release essay]]'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|}

Latest revision as of 16:27, 15 October 2019